phenytoin Injection 50 mg/ml
Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #37379
Bharat Parenterals Limited (BPL) India is a CTD dossier owner and Manufacturer established in 1969. As a CTD dossier owner and Manufacturer, they operate with GMP approvals, ensuring high-quality pharmaceutical products. With production lines designed for tablets, capsules, oral liquids, and dry syrups, this GMP manufacturer reaches numerous countries and regions worldwide. The organization employs over 1000 individuals and is a trusted CTD dossier owner and Manufacturer in the pharmaceutical industry, adhering to GMP standards.
Manufacturer usually replies in 26 days
Phenytoin is an anticonvulsant medication used to treat seizures, epilepsy, cluster-tic syndrome, neuralgia, and peripheral neuropathy. Suppliers of phenytoin market it in the form of oral tablets as well as injectable solutions.
Phenytoin has been in medical use for over 70 years and is one of the pharmaceutical drugs included in the World Health Organization’s list of Essential Medicines that contains the most important medications recommended for a basic health system. Despite its long-standing use, it is still a widely prescribed drug for its indications, with over 2 million prescriptions registered yearly.
Suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified phenytoin manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.
Phenytoin is a relatively low-cost medication. The retail prices per 100 (100mg) tablets of the drug are around 8,00 EUR, whereas 5 (250mg/5ml) vials of the phenytoin injectable solution cost 45,00 EUR to 50,00 EUR.